Skip to content

DR. CAROLINE VAN DEYCK

Active Private limited company (pre-2019)founded 2009active for 16 yearsGuido Gezellestraat 53, 2630 AartselaarKBO/BCE: BE 0820.984.937

Lifetime

15 annual accounts with figures on one time axis
peak of €110,305 in 2024
€100,762▼ 8.7%
lowest -€12,601 in 2017
€70,168▼ 3.7%
peak of €261,046 in 2025
€261,046▲ 4.6%
€62,902▼ 5.5%
Board1 name since 2009
1 director
Documentsfilings and deeds
30-06-202631 days before the deadline
2025micro format
Dividend €58,657Cash from €196,042 to €83,527

Key points

from the 2025 annual accounts

Equity

€261,046 ▲ 4.6%
249,5352024+70,168Profit-58,657Dividend261,0462025

DR. CAROLINE VAN DEYCK paid out €58,657 in dividends. That is 84% of the 2025 profit.

Turnover

≈ €180,000 estimated

The micro format states no turnover.

Filings

15 annual accounts since 2011
AprilJune31 JulyOctober201520202025

The last five annual accounts were filed 2 to 31 days before the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 34,726 companies had the same profile as DR. CAROLINE VAN DEYCK has now. Each dot stands for 87 companies, two years later.

95.2%
were still trading
4.0%
stopped another way
0.7%
went bankrupt
  • Micro
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 34,726 companies, not a prediction for DR. CAROLINE VAN DEYCK. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 30-11-2009
Board & ownership

Recent changes

Registered office moved from Hemiksem to Aartselaar The registered office moved from Kleidaallaan 30, 2620 Hemiksem to Guido Gezellestraat 53 te 2630 Aartselaar · Gazette deed
reappointed as director General meeting of 03-07-2020 · Gazette deed
Algemene Vergadering - Boekjaar General meeting of 30-06-2017 · Gazette deed
Incorporation published on 09-12-2009 · Gazette deed
All 29 events

Comparable companies

same main activity, similar in size and age
Company
DR. CAROLINE VAN DEYCK Aartselaar €323,948 €100,762 80.6% -
Dokter Gertie Vijgen Wuustwezel €330,696 €91,395 70.4% -
HUISARTS TEMMERMAN Bornem €326,981 €106,819 70.6% -
Dr. Louis VAN DER STAPPEN Aarschot €341,175 €98,021 51.6% -
Cabinet Médical Cécile NÉLIS Plombières €311,060 €102,937 74.4% -
Dokter Lien Vandekerkhof Tongeren-Borgloon €318,817 €106,708 95.2% -
Dr. Greet Mentens Lommel €306,669 €98,596 39.1% -

These companies have the same main activity as DR. CAROLINE VAN DEYCK: general medical practice (NACE 86210). They are comparable in size and age: total assets between €307,000 and €341,000, founded between 2008 and 2012.

Official details

Source: KBO
Status
Active since 30-11-2009Normal situation
Activity
General medical practiceNACE 86210and 1 other
Establishment unit
2.183.220.4712620 Hemiksem, since 30-11-2009
Financial year end
31 December
Peppol
Not found in the Peppol Directory
Company details

Annual accounts 2025

€323,948▲ 2.5%
Filing
Filed on 30-06-2026, 31 days before the end of the filing period
Financials

Insights on DR. CAROLINE VAN DEYCK

DR. CAROLINE VAN DEYCK files the micro format. That format states no turnover. The gross margin rose from €49,402 in 2011 to €100,762 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about DR. CAROLINE VAN DEYCK

What is the company number of DR. CAROLINE VAN DEYCK?
The company number of DR. CAROLINE VAN DEYCK is 0820.984.937. The VAT number is the same number with BE in front: BE 0820.984.937.
Where is DR. CAROLINE VAN DEYCK based?
The registered office is at Guido Gezellestraat 53, 2630 Aartselaar.Company details
What does DR. CAROLINE VAN DEYCK do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of DR. CAROLINE VAN DEYCK?
DR. CAROLINE VAN DEYCK is a private limited company (pre-2019) (BVBA).
When was DR. CAROLINE VAN DEYCK founded?
DR. CAROLINE VAN DEYCK was founded on 30-11-2009.
Is DR. CAROLINE VAN DEYCK still active?
Yes, DR. CAROLINE VAN DEYCK is an active enterprise in the KBO register.
What is the turnover of DR. CAROLINE VAN DEYCK?
The turnover in financial year 2025 is ≈ €180,000. This figure is estimated from the gross margin of €100,762 and 30 comparable companies (NACE 86210). It probably lies between €150,000 and €230,000.Financials
Is DR. CAROLINE VAN DEYCK profitable?
In financial year 2025, DR. CAROLINE VAN DEYCK made a profit of €70,168.
Where can I find the annual accounts of DR. CAROLINE VAN DEYCK?
DR. CAROLINE VAN DEYCK filed 15 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR. CAROLINE VAN DEYCK due?
DR. CAROLINE VAN DEYCK must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.